Inspiration

At SPRIM, we produce and share research, insights, and opinions about the world of healthcare science. This makes us stronger, and helps inform the decisions we make with our partners.

Check out our blog, case studies, and publications to stay ahead of common wisdom.

News & Blog

SPRIM’s Quarterly Ventures Day Meeting in New York

SPRIM Ventures in partnership with Tikehau Capital is hosting a Ventures Day event in New York on April 24. … Read More 

Fibronostics Corporate Update

Fibronostics presented its corporate strategy at the second annual TKS 1 Investor Day in Singapore. The event was attended by current and potential investors in the TKS 1 fund, including venture capitalists, strategic investors, family offices and leaders from the healthcare industry. … Read More 

Objective GI Funding Announcement

Objective GI, a gastrointestinal-focused clinical research company, announces a key investment by TKS 1, a joint venture between SPRIM and Tikehau Capital, enabling the company to grow its network of GI-specialty clinical research sites in the United States. … Read More 

Case Studies

Fighting Antibiotic-Associated Diarrhea

A high quality probiotic product containing high concentration of Lactobacillus acidophilus and L. casei demonstrated to prevent Clostridium difficile infection and diarrhea during antibiotic treatment. The trial coordinated by SPRIM was published in the American Journal of Gastroenterology. … Read More 

Improving Patient Outcomes In Intensive Care Units through Nutrition Monitoring

A SPRIM initiated partnership: The GE Healthcare and NestlĂ© Health Science collaboration aims to connect the technology that delivers nutrients to the patient with the advanced analytic technology that measures the specific nutrition a patient needs. … Read More 

Spearheading a Partnership between Two Major Brands to Fight Diabetes

SPRIM spearheaded a public-private partnership between Unilever and Abbott Nutrition and helped create an innovative solution to curb the progression of diabetes in India. A digital platform was created that more than 100,000 people in India used for lifestyle modifications. … Read More 

Publications

Comparison of two probiotics A1:H53 follow-on formulae in chinese infants: Bifidobacterium Animalis Subsp.Lactis HN019 protected against respiratory tract infections

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia